Skip to main content

Day: July 9, 2025

Strong Leach Recoveries and Low Impurities Drive Halleck Creek Closer to Unlocking Its Rare Earth Potential

HighlightsHigh Light Rare Earths Leach RecoveriesPraseodymium (“Pr”) leach recoveries of 85% at optimal conditions Neodymium (“Nd”) leach recoveries of 84% at optimal conditionsEncouraging Heavy Rare Earths Leach RecoveriesTerbium (“Tb”) leach recoveries of 52% at optimal conditions Dysprosium (“Dy”) leach recoveries of 46% at optimal conditionsSignificantly lower impurity elements of iron and aluminumConcentrations of iron and aluminum impurities post leach are approximately 5.0x and 2.9x, respectively, lower than the tests previously performed for the Scoping Study1Atmospheric Tank Leach chosen as the preferred leach methodAtmospheric tank leaching is typically more energy and reagent efficient and less costly than other rare earth leaching methods, such as an acid-bake (i.e. cracking)DENVER, July 09, 2025 (GLOBE...

Continue reading

Blockmate Ventures Inc. Investor Presentation Update

LONDON and AMSTERDAM, July 09, 2025 (GLOBE NEWSWIRE) — Blockmate Ventures Inc. (TSX.V: MATE) (OTCQB: MATEF) (FSE: 8MH1) (“Blockmate” or the “Company”) has released an Investor Presentation which will be presented to a range of sophisticated and wholesale investors over the coming weeks. The presentation includes an updated structure of Blockmate following the launch of Blockmate Mining, announced on May 27, 2025. As an investee, Blockmate Mining is positioned alongside Blockmate’s other major investment in Hivello Holdings. While the nature of the investor presentation and meetings will be to raise capital, Blockmate’s venture strategy is to raise funds directly into the subsidiary companies, rather than the TSX.V-listed Blockmate Ventures Inc. Any subsequent capital raised from investors in the upcoming funding round will be directly...

Continue reading

FirstService to Announce Second Quarter Results on July 24, 2025

TORONTO, July 09, 2025 (GLOBE NEWSWIRE) — FirstService Corporation (TSX and NASDAQ: FSV) (“FirstService”) announced today that it will release its financial results for the second quarter ended June 30, 2025 by press release on Thursday, July 24, 2025 at approximately 7:30 am ET. The conference call to review these financial results will take place at 11:00 am ET on Thursday, July 24, 2025, and will be hosted by D. Scott Patterson, CEO, and Jeremy Rakusin, CFO. This call is being webcast live at the Company’s website at www.firstservice.com. Participants may register for the call here https://register.vevent.com/register/BI4a1fa34337944f40a129a667fecbe126 to receive the dial-in number and their unique PIN. To join the webcast in listen only mode, use this link: https://edge.media-server.com/mmc/p/b34k52bt . It is recommended that...

Continue reading

FTI Consulting Expands Export Controls, Sanctions and Trade Practice with Appointment of Two Industry Leaders

WASHINGTON, July 09, 2025 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Eva Tomlinson as a Senior Managing Director and Breck Heidlberg as a Managing Director in the Export Controls, Sanctions and Trade practice within the Forensic and Litigation Consulting segment. Ms. Tomlinson and Mr. Heidlberg bring more than 40 years of combined expertise in global trade strategy, regulatory compliance and national security guidance, deepening FTI Consulting’s capabilities to lead clients through evolving geopolitical and tariff environments. “Adding Eva and Breck continues our commitment to invest in top-tier global trade talent,” said Anthony J. Ferrante, Global Head of the Cybersecurity and Export Controls, Sanctions and Trade practices. “Both have complementary skillsets and join at an exciting...

Continue reading

Theratechnologies Reports Financial Results for the Second Quarter 2025

Q2 2025 total revenue of $17.7 million, and $36.8 million for the first six months of Fiscal 2025 Positive Adjusted EBITDA1 for the fifth straight quarter Subsequent to quarter end, Theratechnologies entered into a definitive agreement to be acquired by an affiliate of Future PakMONTREAL, July 09, 2025 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today reported business highlights and financial results for the second quarter 2025, ended May 31, 2025. All figures are in U.S. dollars unless otherwise stated. “Demand for EGRIFTA SV® remains very strong and we are witnessing record high patient enrollments. During the first half of our fiscal year, we achieved close to $37 million in revenue despite an estimated negative impact...

Continue reading

Amerigo Reports Q2-2025 Operational Results

Q2-2025 copper production of 15.5 million pounds 2025 production and cash cost1 guidance remain in place $7.6 million returned through Share Buybacks and Dividends in Q2-2025 VANCOUVER, British Columbia, July 09, 2025 (GLOBE NEWSWIRE) — Amerigo Resources Ltd. (TSX: ARG; OTCQX: ARREF) (“Amerigo” or the “Company”) is pleased to announce operational results for the quarter ended June 30, 2025 (“Q2-2025”) from Minera Valle Central (“MVC”), the Company’s 100% owned operation located near Rancagua, Chile. Dollar amounts in this news release are in U.S. dollars (“USD”) unless indicated otherwise. “Operational results during the second quarter of the year were slightly better than expected, as inclement weather production interference at MVC was lower than allowed for in our guidance. MVC produced 15.52 million pounds of copper and 0.39...

Continue reading

Artelo Biosciences Announces Positive Preclinical Efficacy Data for ART26.12 in Osteoarthritis Pain at the 35th Annual International Cannabinoid Research Society Symposium

ART26.12, a Novel FABP5 Inhibitor, Demonstrates Sustained Analgesic Effects Without Tolerance SOLANA BEACH, Calif., July 09, 2025 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatological or neurological conditions, today announced the presentation of preclinical data in an osteaoarthritis (OA) pain model on its lead fatty acid binding protein 5 (FABP5) inhibitor, ART26.12, at the 35th Annual International Cannabinoid Research Society (ICRS) Symposium, being held July 6–10 in Bloomington, Indiana. The presentation, titled “The Fatty Acid Binding Protein 5 Inhibitor ART26.12 Alleviates Osteoarthritis Pain,” was delivered on July 8th by Dr. Martin Kaczocha, Assistant Professor...

Continue reading

Fury Intercepts 32.35m of 1.16% Li2O at the Ninaaskumuwin Discovery

TORONTO, Canada, July 09, 2025 (GLOBE NEWSWIRE) — Fury Gold Mines Limited (TSX and NYSE American: FURY) (“Fury” or the “Company”) is pleased to announce drill results from the maiden drill program, totaling 825 metres (m) in 5 holes, on its Ninaaskumuwin lithium discovery at the Elmer East project located in the Eeyou Istchee James Bay region of Quebec (Figure 1). The drilling targeted a spodumene-bearing pegmatite outcrop, which returned surface samples of up to 3.92% Li2O. Highlights from the drill campaign include 32.35m of 1.16% Li2O from EE24-003 and 22.48m of 1.19% Li2O from EE24-002 (Table 1). The lithium mineralized spodumene-bearing pegmatite remains open at depth and along strike, warranting additional drilling. Highlights:Thick spodumene-bearing pegmatite (>32 m in thickness) was intersected in three holes with individual...

Continue reading

Glucose Health, Inc. Formulations Have Always Been Free of Artificial Colors & Synthetic Dyes—Our Competitors Are Only Playing Catch-Up

BENTONVILLE, Ark., July 09, 2025 (GLOBE NEWSWIRE) — Glucose Health, Inc. (OTC: GLUC), the leading innovator in soluble fiber powdered drink mixes for metabolic wellness, proudly affirms that its flagship brands, GlucoDown® and Fiber Up®, have always used only natural colors derived from vegetables such as beets and carrots—never any artificial synthetic dyes. Unlike our legacy competitors such as Metamucil® (The Procter & Gamble Company, P&G), which have long relied on synthetic dyes like Yellow 6 and Red 40, Glucose Health, Inc. committed to nutritionally efficacious, clean-label formulation, from our GlucoDown® brand’s inception in 2017 – more than eight years ago. Now, amid the regulatory shift under U.S. Health and Human Services Secretary Robert F. Kennedy Jr., our much larger competitors are facing pressure to finally...

Continue reading

Aurora Spine Announces Initial Surgeries using its AERO™ Lumbar Fusion System

CARLSBAD, CALIFORNIA, July 09, 2025 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in innovative spine and interventional pain management solutions, today announced initial surgeries using Aurora Spine’s newest product, the AERO™ Lumbar Fusion System, have commenced. The minimally invasive procedures using the AERO were conducted by two different surgeons, one ortho surgeon and one interventionalist. The initial surgeries performed were procedures done on the lumbar part of the spine. “We are extremely pleased to announce our newest product: the AERO Lumbar Fusion System, has begun to be used by surgeons and implanted into patients,” said Trent Northcutt, President and CEO of Aurora Spine. “Initial feedback has been extremely positive, and we expect additional...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.